Innovative project establishes national infrastructure for superconductivity research, addressing energy and healthcare challenges.
The IRIS (Innovative Research Infrastructure on Applied Superconductivity) project establishes a distributed and integrated national infrastructure in Italy to support long-term research and development in superconducting technologies. Driven by the increasing demands of next-generation scientific facilities—such as the Future Circular Collider and the Muon Collider—and by the emergence of high-temperature superconductors (HTS), IRIS addresses the full technological chain from materials and conductors to magnets and system-level demonstrators. The infrastructure is organized around a central hub at INFN–LASA in Milan and five specialized nodes (Genoa, Frascati, Naples, Lecce, and Salerno), providing complementary capabilities in materials science, diagnostics, magnet engineering, and large-scale testing. Two flagship demonstrators, the Green Superconducting Line (GSL) for high-power energy transmission and the Energy-Saving Magnet (ESMA) for accelerator applications, play a key role in validating integrated technologies. By combining scientific excellence with strong industrial links, IRIS aims to bridge the gap between fundamental research and real-world applications, contributing to both future research infrastructures and societal challenges in energy and healthcare.
No takes yet. Share an insight, caveat, or question.
Rossi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: